Evaluation of Lovelace Health Systems chronic pelvic pain protocol

Kephart W, W Kephart
The American journal of managed care · 1999 · vol. 5(5 Suppl) , pp. S309–15 · PMID:10537663 · W110530025
Other OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-13 ⓘ

Lovelace Health Systems' chronic pelvic pain protocol, utilizing a GnRH agonist algorithm, successfully benefited patients, physicians, and healthcare budgets since its 1997 introduction.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Although laparoscopy has been considered the gold standard for the diagnosis of endometriosis, it often fails to detect the disease and provide lasting pain relief. Motivated by concerns for patient well-being, treatment efficacy, and cost containment, Lovelace Health Systems of Albuquerque, New Mexico, turned to the Lovelace Chronic Pelvic Pain Protocol, based on a chronic pelvic pain algorithm used to identify potential candidates for therapy with gonadotropin-releasing hormone agonist (GnRH agonist). Since the protocol's introduction in January 1997, empiric therapy with GnRH agonist has proved beneficial to patients, physicians, and healthcare system budgets.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Clinical Protocols Clinical Protocols Decision Making Decision Making Pelvic Pain Algorithms Algorithms Chronic Disease Chronic Disease Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Female Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Health Care Costs

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

europepmc
last seen: 2026-10-09T06:09:53.026058+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T20:59:07.345995+00:00
License: CC0 · commercial use OK